Stockscreener 앱 받기
6.5295
0.01%
-0.0005
전일 마감가:
$6.53
열려 있는:
$6.35
하루 거래량:
4,403
Relative Volume:
0.20
시가총액:
$108.47M
수익:
$22.43M
순이익/손실:
$-17.19M
주가수익비율:
-4.9138
EPS:
-1.3288
순현금흐름:
$-10.02M
1주 성능:
+4.31%
1개월 성능:
+17.82%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$6.35
$6.5295
1주일 범위
$6.22
$6.80
52주 변동 폭
$4.7237
$6.99
Bioharvest Sciences Inc Stock (BHST) Company Profile
BHST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
6.5295 | 108.47M | 22.43M | -17.19M | -10.02M | -1.3288 |
|
KHC
Kraft Heinz Co
|
28.39 | 34.78B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
54.83 | 30.53B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.69 | 28.52B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
75.33 | 20.04B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.07 | 16.23B | 11.92B | 805.04M | 1.01B | 1.46 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Maxim Group | Buy |
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
Craig-Hallum Recommends BioHarvest Sciences (BHST) with Strong Buy Rating | BHST Stock News - GuruFocus
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time | BHST Stock News - GuruFocus
BioHarvest Sciences to Announce Q1 2025 Financial Results - TipRanks
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time - Newsfile
BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock? - MSN
Analysts Set Expectations for BHST Q1 Earnings - Defense World
Research Analysts Set Expectations for BHST Q2 Earnings - The AM Reporter
What is HC Wainwright’s Estimate for BHST Q2 Earnings? - Defense World
BioHarvest Sciences’ (BHST) Buy Rating Reaffirmed at HC Wainwright - Defense World
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target - Investing.com Australia
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target By Investing.com - Investing.com Canada
Here's Why BioHarvest Sciences (NASDAQ:BHST) Can Afford Some Debt - simplywall.st
Q1 Earnings Forecast for BHST Issued By Diamond Equity - Defense World
BioHarvest Sciences Reports Strong Revenue Growth and Strategic Expansion - TipRanks
BioHarvest Sciences Reports Strong Growth Amid Challenges - TipRanks
BioHarvest CEO talks Nasdaq uplisting, profit targetsICYMI - Proactive financial news
BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
BioHarvest shares rise after Q4 results show strong demand for VINIA products - Proactive financial news
Small cap wrap: Ideal Power, Voyageur Pharmaceuticals, North Bay Resources, Trust Stamp... - Proactive Investors
BioHarvest Sciences reports record-breaking 2024 revenue and expansion milestones - Proactive financial news
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates - MSN
BioHarvest Sciences Reports Strong Financial Growth and Strategic Partnership - TipRanks
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results - Newsfile
Contrasting CureVac (NASDAQ:CVAC) & BioHarvest Sciences (NASDAQ:BHST) - The AM Reporter
BioHarvest Sciences (BHST) to Release Earnings on Monday - Defense World
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength? - Nasdaq
BioHarvest Sciences to Announce Q4 and Full Year 2024 Financial Results - TipRanks
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time - Newsfile
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
BIOHARVEST SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound - Proactive Investors USA
BioHarvest’s Olive Cell Compound Shows Promise in Tackling Liver Fat Accumulation - TipRanks
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells - Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells - Benzinga
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive financial news
Bioharvest Sciences Inc (BHST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.12%
0.91%
자본화:
|
볼륨(24시간):